
|Articles|January 28, 2015
Segment 6: Learning About CancerLinQ as It Rolls Out
Daniel Hayes, MD, explains the implementation of the American Society of Clinical Oncology's CancerLinQ for beta testing.
Advertisement
Moderator Surabhi Dangi-Garimella asked Daniel Hayes, MD, who has been elected president of the American Society of Clinical Oncology (ASCO) for the term beginning in June 2016, what changes practices would have to adopt to implement ASCO’s CancerLinQ.
Currently, ASCO is rolling out CancerLinQ for beta testing in a number of practices, but he admits they don’t really know how it will function until they put it to work.
“I think as it becomes increasingly more successful, other practices will see the advantages of being enrolled,” he said.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma
4
More Potent and Tolerable, Azenosertib Advances as the Leading WEE1 Inhibitor
5




